Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine - Jun 14, 2024 - Novavax Investor Relations ir.novavax.com Submitted by novavaxcom6691 on June 16, 2024 at 12:18 PM in business No comments 28
First Doses of R21/Matrix-M™ Malaria Vaccine Shipped to Africa - May 20, 2024 - Novavax Investor Relations ir.novavax.com Submitted by novavaxcom6691 on May 22, 2024 at 3:09 PM in health No comments 63
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. - Oct 3, 2023 - Novavax Investor Relations ir.novavax.com Submitted by novavaxcom6691 on October 4, 2023 at 7:52 PM in business No comments 33